Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H20O4 |
Molecular Weight | 264.3169 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12[C@H](C)C(=O)C[C@@]3([H])[C@]1(C)CC[C@@]3([C@H](C)C(O)=O)C2=O
InChI
InChIKey=UNPYYTKZOHYHMZ-DQMQVFGMSA-N
InChI=1S/C15H20O4/c1-7-9(16)6-10-14(3)4-5-15(10,8(2)13(18)19)12(17)11(7)14/h7-8,10-11H,4-6H2,1-3H3,(H,18,19)/t7-,8-,10+,11+,14+,15+/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12645053Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18329884
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12645053
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18329884
Santonic acid is an organic compound containing both carboxylic acid and ketone functionality. It is a transformation product of santonin discovered by Hvoslev in 1863, and rediscovered some ten years later by Cannizzaro and Sestini. Hvoslev had found that the action of concentrated sodium hydroxide on santonin gave rise to an acid, isomeric with santoninic acid, named santonic acid in in 1863. Biological studies indicated that a new copper(II) complex of santonic acid displays interesting potential antitumoral actions.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12645053
Curator's Comment: Hvoslev had found that the action of concentrated sodium hydroxide on santonin gave rise to an acid, isomeric with santoninic acid, named santonic acid in in 1863.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Tumor cell growth Sources: https://www.ncbi.nlm.nih.gov/pubmed/18329884 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18329884
The copper complex of Santonic acid (500 uM) inhibited 55% of basal tumoral osteoblasts (UMR106) cell proliferation.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Santonic acid
Created by
admin on Sat Dec 16 19:07:16 GMT 2023 , Edited by admin on Sat Dec 16 19:07:16 GMT 2023
|
PRIMARY | |||
|
13862
Created by
admin on Sat Dec 16 19:07:16 GMT 2023 , Edited by admin on Sat Dec 16 19:07:16 GMT 2023
|
PRIMARY | |||
|
91618089
Created by
admin on Sat Dec 16 19:07:16 GMT 2023 , Edited by admin on Sat Dec 16 19:07:16 GMT 2023
|
PRIMARY | |||
|
DTXSID3046871
Created by
admin on Sat Dec 16 19:07:16 GMT 2023 , Edited by admin on Sat Dec 16 19:07:16 GMT 2023
|
PRIMARY | |||
|
0735572T0M
Created by
admin on Sat Dec 16 19:07:16 GMT 2023 , Edited by admin on Sat Dec 16 19:07:16 GMT 2023
|
PRIMARY | |||
|
510-35-0
Created by
admin on Sat Dec 16 19:07:16 GMT 2023 , Edited by admin on Sat Dec 16 19:07:16 GMT 2023
|
PRIMARY | |||
|
138622
Created by
admin on Sat Dec 16 19:07:16 GMT 2023 , Edited by admin on Sat Dec 16 19:07:16 GMT 2023
|
PRIMARY | |||
|
m9767
Created by
admin on Sat Dec 16 19:07:16 GMT 2023 , Edited by admin on Sat Dec 16 19:07:16 GMT 2023
|
PRIMARY | Merck Index |
SUBSTANCE RECORD